Implementation of Physical Cancer Rehabilitation Programmes in a European Healthcare System.
An Evaluation of a Patient-directed Strategy Compared With a Multi-faceted Strategy to Implement Physical Cancer Rehabilitation Programmes; a Controlled Before and After Study.
1 other identifier
interventional
10
1 country
1
Brief Summary
The aim of this study is to develop and identify the most effective strategy to implement PCRPs into daily care. We want to assess the added value of a multi-faceted strategy compared with a single-faceted patient-directed strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2014
CompletedFirst Posted
Study publicly available on registry
July 31, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedSeptember 7, 2015
August 1, 2015
July 21, 2014
September 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The percentage of screened patients with the screening tool recommended by the Dutch guideline 'Cancer Rehabilitation'.
A pre- and post measurement of 'the percentage of screened patients with the screening tool recommended by the Dutch guideline 'Cancer Rehabilitation'' will be done. The differences between the pre- and post measurement will be measured.
baseline and at follow-up
The percentage of referrals to PCRPs where needed, according to the Dutch guideline 'Cancer Rehabilitation'.
A pre- and post measurement of 'The percentage of referrals to PCRPs where needed, according to the Dutch guideline 'Cancer Rehabilitation'' will be done. The differences between the pre- and post measurement will be measured.
baseline and at follow-up
Secondary Outcomes (3)
Quality of life
baseline and at follow-up
Patientempowerment
baseline and at follow-up
Remaining quality indicators of the Dutch guideline 'Cancer Rehabilitation'.
baseline and at follow-up
Other Outcomes (2)
Process-evaluation
at follow-up
Cost
at follow-up
Study Arms (2)
The patient-directed (PD) strategy
OTHERA single-faceted patient-directed (PD) strategy that will embed the change at patient level.
The multi-faceted (MF) strategy
OTHERA multi-faceted (MF) strategy that will embed the change at the patient, professional and organizational levels.
Interventions
The patient-directed strategy will be designed to embed the success of implementation of PCRPs by influencing the patients.
The multi-faceted strategy will be designed to embed the success by not only influencing the patients, but also professionals and organizational aspects.
Eligibility Criteria
You may qualify if:
- patients:
- preferably (history of) cancer in the gastro-intestinal, reproductive and/or urological system; successful primary treatment; and without recurrence/metastases.
- Adults
- Diagnosed in one of the participating hospitals
- Able to read and understand Dutch
- Healthcare professionals:
- involved in cancer care in one of the participating hospitals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud University Nijmegen Medical Center
Nijmegen, Gelderland, 6500HB, Netherlands
Related Publications (1)
IJsbrandy C, Ottevanger PB, Groen WG, Gerritsen WR, van Harten WH, Hermens RP. Study protocol: an evaluation of the effectiveness, experiences and costs of a patient-directed strategy compared with a multi-faceted strategy to implement physical cancer rehabilitation programmes for cancer survivors in a European healthcare system; a controlled before and after study. Implement Sci. 2015 Sep 7;10:128. doi: 10.1186/s13012-015-0312-3.
PMID: 26345182DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
C. IJsbrandy, MD
Radboud Univeristy Medical Centre Nijmegen
- STUDY CHAIR
R.P.M.G. Hermens, PhD
Radboud Univeristy Medical Centre Nijmegen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
July 21, 2014
First Posted
July 31, 2014
Primary Completion
October 1, 2017
Last Updated
September 7, 2015
Record last verified: 2015-08